Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Dow
Federal Trade Commission
Healthtrust
US Department of Justice
Deloitte
Boehringer Ingelheim
Teva
Fuji

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062602

« Back to Dashboard

NDA 062602 describes NYSTATIN AND TRIAMCINOLONE ACETONIDE, which is a drug marketed by Alpharma Us Pharms, Amneal Pharms Llc, Crown Labs Inc, Dr Reddys Labs Ltd, Fougera Pharms Inc, Glenmark Pharms Ltd, Perrigo New York, Perrigo Uk Finco, Pharmafair, Taro, Akorn, Riconpharma Llc, Strides Pharma, and Teligent Pharma Inc, and is included in twenty-three NDAs. It is available from seventeen suppliers. Additional details are available on the NYSTATIN AND TRIAMCINOLONE ACETONIDE profile page.

The generic ingredient in NYSTATIN AND TRIAMCINOLONE ACETONIDE is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
Summary for 062602
Tradename:NYSTATIN AND TRIAMCINOLONE ACETONIDE
Applicant:Fougera Pharms Inc
Ingredient:nystatin; triamcinolone acetonide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 062602
Ingredient-typePolyenes
Mechanism of ActionCorticosteroid Hormone Receptor Agonists
Suppliers and Packaging for NDA: 062602
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide OINTMENT;TOPICAL 062602 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0089 N 0168-0089-15
NYSTATIN AND TRIAMCINOLONE ACETONIDE nystatin; triamcinolone acetonide OINTMENT;TOPICAL 062602 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0089 N 0168-0089-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength100,000 UNITS/GM;0.1%
Approval Date:Oct 9, 1985TE:ATRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
US Army
Farmers Insurance
Federal Trade Commission
Boehringer Ingelheim
Cipla
QuintilesIMS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.